Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
ALZT-OP1 Cromolyn sodium, Intal,
Alzheimer's Disease (Phase 3) AZTherapies, Inc. Amyloid-Related, Inflammation Combination, Small Molecule
Aducanumab BIIB037 Alzheimer's Disease (Phase 3) Biogen, Neurimmune Amyloid-Related Immunotherapy (passive)
BAN2401 mAb158 Alzheimer's Disease (Phase 3) Biogen, Eisai Co., Ltd. Amyloid-Related Immunotherapy (passive)
GV-971 sodium oligomannate,
sodium oligo-mannurarate
Alzheimer's Disease (Phase 3) Shanghai Green Valley Pharmaceuticals Amyloid-Related, Inflammation Small Molecule
Gantenerumab RO4909832,
Alzheimer's Disease (Phase 3) Chugai Pharmaceutical Co., Ltd., Hoffmann-La Roche Amyloid-Related Immunotherapy (passive)
Levetiracetam Keppra Alzheimer's Disease (Phase 3), Parkinson's Disease (Discontinued) UCB S.A. Amyloid-Related, Other Small Molecule Epilepsy and Partial Seizures in U.S., European Union, plus about 20 other countries
Solanezumab LY2062430 Alzheimer's Disease (Phase 3) Eli Lilly & Co. Amyloid-Related Immunotherapy (passive) None